Research Article | Open Access
Genes Involved in Human Ribosome Biogenesis are Transcriptionally Upregulated in Colorectal Cancer
Microarray gene expression profiling comprising 168 colorectal adenocarcinomas and 10 normal mucosas showed that over 79% of the genes involved in human ribosome biogenesis are significantly upregulated (, ) when compared to normal mucosa. Overexpression was independent of microsatellite status. The promoters of the genes studied showed a significant enrichment for several transcription factor binding sites. There was a significant correlation between the number of binding site targets for these transcription factors and the observed gene transcript upregulation. The upregulation of rRNA processing genes points towards a coordinated process enabling the overproduction of matured ribosomal structures.
The three Supplementary Tables provide detailed information regarding all the genes mentioned in this study, their log2 values, chromosomal location and array probes.
- C. G. Proud, “Signalling to translation: how signal transduction pathways control the protein synthetic machinery,” Biochemical Journal, vol. 403, no. 2, pp. 217–234, 2007.
- B. W. Stewart and P. Kleihues, World Cancer Report, World Health Organization Press, Lyon, France, 2003.
- H. Kasai, D. Nadano, E. Hidaka et al., “Differential expression of ribosomal proteins in human normal and neoplastic colorectum,” Journal of Histochemistry and Cytochemistry, vol. 51, no. 5, pp. 567–573, 2003.
- K. Pogue-Geile, J. R. Geiser, M. Shu et al., “Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein,” Molecular and Cellular Biology, vol. 11, no. 8, pp. 3842–3849, 1991.
- A. Killian, N. Sarafan-Vasseur, R. Sesboüé et al., “Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis,” Genes Chromosomes and Cancer, vol. 45, no. 9, pp. 874–881, 2006.
- Y. Couté, J. A. Burgess, J.-J. Diaz et al., “Deciphering the human nucleolar proteome,” Mass Spectrometry Reviews, vol. 25, no. 2, pp. 215–234, 2006.
- E. R. Fearon and B. Vogelstein, “A genetic model for colorectal tumorigenesis,” Cell, vol. 61, no. 5, pp. 759–767, 1990.
- A. J. Clark, R. Barnetson, S. M. Farrington, and M. G. Dunlop, “Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent?,” Familial Cancer, vol. 3, no. 2, pp. 85–91, 2004.
- F. Mansilla, K. Birkenkamp-Demtröder, M. Kruhøffer et al., “Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups,” British Journal of Cancer, vol. 96, no. 12, pp. 1896–1903, 2007.
- K. A. Dugan, M. A. Wood, and M. D. Cole, “TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis,” Oncogene, vol. 21, no. 38, pp. 5835–5843, 2002.
- S. Grisendi, C. Mecucci, B. Falini, and P. P. Pandolfi, “Nucleophosmin and cancer,” Nature Reviews Cancer, vol. 6, no. 7, pp. 493–505, 2006.
- N. P. S. Crawford, R. C. Walker, L. Lukes, J. S. Officewala, R. W. Williams, and K. W. Hunter, “The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival,” Clinical & Experimental Metastasis, vol. 25, no. 4, pp. 357–369, 2008.
- P. L. Opresko, J. P. Calvo, and C. von Kobbe, “Role for the Werner syndrome protein in the promotion of tumor cell growth,” Mechanisms of Ageing and Development, vol. 128, no. 7-8, pp. 423–436, 2007.
- C.-H. Wu, D. Sahoo, C. Arvanitis, N. Bradon, D. L. Dill, and D. W. Felsher, “Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis,” PLoS Genetics, vol. 4, no. 6, article e1000090, pp. 1–16, 2008.
- I. Grummt, “Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus,” Genes & Development, vol. 17, no. 14, pp. 1691–1702, 2003.
- D. Ruggero and P. P. Pandolfi, “Does the ribosome translate cancer?,” Nature Reviews Cancer, vol. 3, no. 3, pp. 179–192, 2003.
- Q. Wang, Q. Ding, Z. Dong, R. A. Ehlers, and B. M. Evers, “Downregulation of mitogen-activated protein kinases in human colon cancers,” Anticancer Research, vol. 20, no. 1A, pp. 75–83, 2000.
- T.-H. Ying, Y.-H. Hsieh, Y.-S. Hsieh, and J.-Y. Liu, “Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells,” Cell Biology International, vol. 32, no. 2, pp. 210–216, 2008.
- H. Yoshimura, D. K. Dhar, H. Kohno et al., “Prognostic impact of hypoxia-inducible factors 1 and 2 in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression,” Clinical Cancer Research, vol. 10, no. 24, pp. 8554–8560, 2004.
- K. Boon, H. N. Caron, R. van Asperen et al., “N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis,” The EMBO Journal, vol. 20, no. 6, pp. 1383–1393, 2001.
Copyright © 2009 Francisco Mansilla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.